Trump ahead of New Hampshire speech: Lewandowski would be 'fantastic' senator

September 3, 2020 0 By JohnValbyNation

President TrumpDonald John TrumpSenate advances public lands bill in late-night vote Warren, Democrats urge Trump to back down from veto threat over changing Confederate-named bases Esper orders ‘After Action Review’ of National Guard’s role in protests MORE on Thursday offered praise for his former campaign manager Corey LewandowskiCorey R. LewandowskiTrump taps Lewandowski, Bossie for Commission on Presidential Scholars The Hill’s Campaign Report: Trump ramps up attacks against Twitter Bossie, Lewandowski warned Trump he was in trouble in 2020: report MORE, telling a local radio host that Lewandowki would make a “great” addition to the Senate should he choose to run.

Trump, speaking on “New Hampshire Today” ahead of his rally in the state Thursday night, told host Jack Heath that Lewandowski would make a “great senator” for New Hampshire should he choose to run in 2020 against┬áSen. Jeanne ShaheenCynthia (Jeanne) Jeanne ShaheenWarren, Democrats urge Trump to back down from veto threat over changing Confederate-named bases Mnuchin indicates openness to more PPP loans in next COVID-19 relief bill On The Money: GOP turning against new round of ,200 rebate checks | Millions of Americans frustrated by delayed unemployment checks | Senate votes to give coronavirus relief program more flexibility MORE (D-N.H.), according to CBS News.

ADVERTISEMENT

“Well, first of all, I have to tell you that I think he would be fantastic, he’s got great energy,” he said in the interview. “He’s terrific on television, you’ve seen. He’s a really good guy, I like him a lot. I like him, I like his family, I like everything about him. I think Corey is a fantastic guy.”

“And I don’t think he’s made that decision yet,”┬áTrump added. “I will say this, if he ran he would be a great senator. If he ran and won he’d be a great senator. He would be great for New Hampshire, he’d be great for the country. He has got a tremendous drive and that drive would be put to the people of New Hampshire’s benefit and the country’s benefit.”

Lewandowski previously told The Hill last week that he was considering a bid against Shaheen, which would mark his first personal entrance into politics. The former Trump campaign manager left the president’s team during the 2016 primary season after an altercation with a female Breitbart News reporter led to allegations of assault.

In a statement, Lewandowski said last week that Shaheen was voting in “lock step” with Democratic Party leadership.

Click Here: collingwood magpies 2019 training guernsey

“Jeannie Shaheen has failed the people of NH by voting in lock step with Chuck SchumerChuck SchumerOvernight Health Care: US showing signs of retreat in battle against COVID-19 | Regeneron begins clinical trials of potential coronavirus antibody treatment | CMS warns nursing homes against seizing residents’ stimulus checks Schumer requests briefing with White House coronavirus task force as cases rise Schumer on Trump’s tweet about 75-year-old protester: He ‘should go back to hiding in the bunker’ MORE and Nancy PelosiNancy PelosiTrump on collision course with Congress over bases with Confederate names Black lawmakers unveil bill to remove Confederate statues from Capitol Pelosi: Georgia primary ‘disgrace’ could preview an election debacle in November MORE,” Lewandowski told The Hill. “The people of NH deserve better. If I run, I would be a voice for all the people of NH.”

Democrats in the state, meanwhile, have characterized the former campaign operative as a “craven lobbyist” with credible accusations of assault against him.

“Corey Lewandowski is a craven lobbyist who has been credibly accused of assault many times and is chomping at the bit to strip away Granite Staters’ health care,” a spokesman for New Hampshire Democrats said last week. “Meanwhile, Senator Shaheen is making a difference for New Hampshire families, leading efforts in the Senate to expand access to health care and taking on the big drug companies to lower the costs of prescription drugs. The contrast couldn’t be more clear.”